These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10479277)

  • 1. Probing the binding of indolactam-V to protein kinase C through site-directed mutagenesis and computational docking simulations.
    Wang S; Liu M; Lewin NE; Lorenzo PS; Bhattacharrya D; Qiao L; Kozikowski AP; Blumberg PM
    J Med Chem; 1999 Sep; 42(18):3436-46. PubMed ID: 10479277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of binding of high-affinity ligands to protein kinase C: prediction of the binding modes through a new molecular dynamics method and evaluation by site-directed mutagenesis.
    Pak Y; Enyedy IJ; Varady J; Kung JW; Lorenzo PS; Blumberg PM; Wang S
    J Med Chem; 2001 May; 44(11):1690-701. PubMed ID: 11356104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCdelta and discovery of an ILV analogue of improved isozyme selectivity.
    Kozikowski AP; Wang S; Ma D; Yao J; Ahmad S; Glazer RI; Bogi K; Acs P; Modarres S; Lewin NE; Blumberg PM
    J Med Chem; 1997 Apr; 40(9):1316-26. PubMed ID: 9135029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of RasGRP binding to high-affinity PKC ligands.
    Rong SB; Enyedy IJ; Qiao L; Zhao L; Ma D; Pearce LL; Lorenzo PS; Stone JC; Blumberg PM; Wang S; Kozikowski AP
    J Med Chem; 2002 Feb; 45(4):853-60. PubMed ID: 11831896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolactam and benzolactam compounds as new medicinal leads with binding selectivity for C1 domains of protein kinase C isozymes.
    Irie K; Nakagawa Y; Ohigashi H
    Curr Pharm Des; 2004; 10(12):1371-85. PubMed ID: 15134488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular modeling and site-directed mutagenesis studies of a phorbol ester-binding site in protein kinase C.
    Wang S; Kazanietz MG; Blumberg PM; Marquez VE; Milne GW
    J Med Chem; 1996 Jun; 39(13):2541-53. PubMed ID: 8691452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation.
    Endo Y; Takehana S; Ohno M; Driedger PE; Stabel S; Mizutani MY; Tomioka N; Itai A; Shudo K
    J Med Chem; 1998 Apr; 41(9):1476-96. PubMed ID: 9554881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into the interactions of phorbol ester and bryostatin complexed with protein kinase C: a comparative molecular dynamics simulation study.
    Thangsunan P; Tateing S; Hannongbua S; Suree N
    J Biomol Struct Dyn; 2016 Jul; 34(7):1561-75. PubMed ID: 26292580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular sensitization to cis-diamminedichloroplatinum(II) by novel analogues of the protein kinase C activator lyngbyatoxin A.
    Basu A; Kozikowski AP; Sato K; Lazo JS
    Cancer Res; 1991 May; 51(10):2511-4. PubMed ID: 2021930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, computer modeling and biological evaluation of novel protein kinase C agonists based on a 7-membered lactam moiety.
    Endo Y; Shimazu M; Fukasawa H; Driedger PE; Kimura K; Tomioka N; Itai A; Shudo K
    Bioorg Med Chem Lett; 1999 Jan; 9(2):173-8. PubMed ID: 10021922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling studies on the structural determinants for the DAG/phorbol ester binding to C1 domain.
    Rahman GM; Das J
    J Biomol Struct Dyn; 2015; 33(1):219-32. PubMed ID: 24666138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformationally constrained analogues of diacylglycerol (DAG). 23. Hydrophobic ligand-protein interactions versus ligand-lipid interactions of DAG-lactones with protein kinase C (PK-C).
    Tamamura H; Sigano DM; Lewin NE; Peach ML; Nicklaus MC; Blumberg PM; Marquez VE
    J Med Chem; 2004 Sep; 47(20):4858-64. PubMed ID: 15369389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of alteration of the heterocyclic nucleus of ILV on its isoform selectivity for PKC. Palladium catalyzed route to benzofuran analogues of ILV.
    Kozikowski AP; Ma D; Du L; Lewin NE; Bumberg PM
    Farmaco; 1995 Jun; 50(6):425-30. PubMed ID: 7669180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward the development of new medicinal leads with selectivity for protein kinase C isozymes.
    Irie K; Nakagawa Y; Ohigashi H
    Chem Rec; 2005; 5(4):185-95. PubMed ID: 16041745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase Cdelta: possible correlation with tumor-promoting activity.
    Bögi K; Lorenzo PS; Szállási Z; Acs P; Wagner GS; Blumberg PM
    Cancer Res; 1998 Apr; 58(7):1423-8. PubMed ID: 9537243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of 8-octyl-benzolactam-V9, a selective activator for protein kinase C epsilon and eta.
    Nakagawa Y; Irie K; Yanagita RC; Ohigashi H; Tsuda K; Kashiwagi K; Saito N
    J Med Chem; 2006 May; 49(9):2681-8. PubMed ID: 16640328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding mode prediction of aplysiatoxin, a potent agonist of protein kinase C, through molecular simulation and structure-activity study on simplified analogs of the receptor-recognition domain.
    Ashida Y; Yanagita RC; Takahashi C; Kawanami Y; Irie K
    Bioorg Med Chem; 2016 Sep; 24(18):4218-4227. PubMed ID: 27436807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D.
    Wang QJ; Fang TW; Yang D; Lewin NE; Van Lint J; Marquez VE; Blumberg PM
    Mol Pharmacol; 2003 Dec; 64(6):1342-8. PubMed ID: 14645664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C. Modeling of the binding site and prediction of binding constants.
    Wang S; Milne GW; Nicklaus MC; Marquez VE; Lee J; Blumberg PM
    J Med Chem; 1994 Apr; 37(9):1326-38. PubMed ID: 8176711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformationally constrained analogues of diacylglycerol. 26. Exploring the chemical space surrounding the C1 domain of protein kinase C with DAG-lactones containing aryl groups at the sn-1 and sn-2 positions.
    Kang JH; Benzaria S; Sigano DM; Lewin NE; Pu Y; Peach ML; Blumberg PM; Marquez VE
    J Med Chem; 2006 Jun; 49(11):3185-203. PubMed ID: 16722637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.